Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EQUINIX INC Director's Dealing 2026

Feb 19, 2026

29917_dirs_2026-02-19_9f958ce3-a33a-4f9f-adf5-36cd270f359a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EQUINIX INC (EQIX)
CIK: 0001101239
Period of Report: 2026-02-17

Reporting Person: Fox-Martin Adaire (Director, CEO and President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-17 Common Stock M 2669 Acquired 17558.661 Direct
2026-02-17 Common Stock M 5297 Acquired 22855.661 Direct
2026-02-18 Common Stock S 101 $925.5764 Disposed 22754.661 Direct
2026-02-18 Common Stock S 806 $926.7666 Disposed 21948.661 Direct
2026-02-18 Common Stock S 403 $927.3414 Disposed 21545.661 Direct
2026-02-18 Common Stock S 506 $928.6281 Disposed 21039.661 Direct
2026-02-18 Common Stock S 174 $929.3094 Disposed 20865.661 Direct
2026-02-18 Common Stock S 280 $930.431 Disposed 20585.661 Direct
2026-02-18 Common Stock S 200 $932.083 Disposed 20385.661 Direct
2026-02-18 Common Stock S 120 $933.7598 Disposed 20265.661 Direct
2026-02-18 Common Stock S 120 $934.3334 Disposed 20145.661 Direct
2026-02-18 Common Stock S 114 $936.9416 Disposed 20031.661 Direct
2026-02-18 Common Stock S 86 $938.6712 Disposed 19945.661 Direct
2026-02-18 Common Stock S 410 $939.3293 Disposed 19535.661 Direct
2026-02-18 Common Stock S 150 $940.1828 Disposed 19385.661 Direct
2026-02-18 Common Stock S 320 $941.6838 Disposed 19065.661 Direct
2026-02-18 Common Stock S 200 $942.774 Disposed 18865.661 Direct
2026-02-18 Common Stock S 240 $943.835 Disposed 18625.661 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-17 Restricted Stock Units $0 M 2669 Disposed Common Stock (2669) Direct
2026-02-17 Restricted Stock Unit $0 A 10594 Acquired Common Stock (10594) Direct
2026-02-17 Restricted Stock Unit $0 M 5297 Disposed Common Stock (5297) Direct

Footnotes

F1: 32.243 shares acquired under the Equinix, Inc. Employee Stock Purchase Plan on February 13, 2026.

F2: Shares were sold pursuant to a 10b5-1 Trading Plan in order to raise funds to pay the required withholding tax pursuant to the vesting of RSUs.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $925.00 to $925.95, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 through 18 to this Form 4.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $926.01 to $927.00 inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $927.04 to $928.00 inclusive.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $928.07 to $929.07 inclusive.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $929.13 to $929.55 inclusive.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $930.27 to $930.72 inclusive.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $931.85 to $932.29 inclusive.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $933.18 to $934.09 inclusive.

F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $934.30 to $934.44 inclusive.

F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $936.60 to $937.29 inclusive.

F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $937.82 to $938.75 inclusive.

F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $938.90 to $939.90 inclusive.

F15: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $940.00 to $940.51 inclusive.

F16: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $941.53 to $942.41 inclusive.

F17: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $942.60 to $942.89 inclusive.

F18: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $943.71 to $943.86 inclusive.

F19: On March 7, 2024 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2024. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2025, 25% will vest on February 15, 2026 and the remaining 25% will vest on February 15, 2027, subject solely to continued service.

F20: Restricted stock unit award expires upon reporting person's termination of service.

F21: On March 11, 2025 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2025. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2026, 25% will vest on February 15, 2027 and the remaining 25% will vest on February 15, 2028, subject solely to continued service.